Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 139 Neoplasms 118 Prostatic Neoplasms 64 Lung Neoplasms 48 Head and Neck Neoplasms 46 Colorectal Neoplasms 38 Ovarian Neoplasms 33 Uterine Cervical Neoplasms 29 Endometrial Neoplasms 23 Motor Activity 22 Neoplasm Metastasis 20 Multiple Myeloma 20 Pancreatic Neoplasms 19 Brain Neoplasms 19 Rectal Neoplasms 18 Lymphoma 17 Colonic Neoplasms 17 Pain 16 Gastrointestinal Neoplasms 16 Fatigue 16 Carcinoma, Non-Small-Cell Lung 16 Leukemia 15 Depression 15 Oropharyngeal Neoplasms 13 Melanoma 13 Anxiety Disorders 13 Urinary Bladder Neoplasms 12 Hematologic Neoplasms 12 Esophageal Neoplasms 12 Stomach Neoplasms 11

Interventions

S 3304 2 Zoledronic Acid 1 Surveys and Questionnaires 1 Rubidium-82 1 Neoadjuvant Therapy 1 Indocyanine Green 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neovascularization, Pathologic × Surveys and Questionnaires × Clear all

NCT05741671 2023-02-23

MYOVASC

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Leiomyoma, Neovascularization, Pathologic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡